EVS COMMUNICATES THE RESULTS OF THE ORDINARY GENERAL MEETING
EVS Broadcast Equipment SA, leading provider of live video production systems, held its Ordinary General Meeting on May 20, 2025.
In total 154 shareholders representing 3,726,794 shares, or 26.01% of the company shares, attended (by proxy and physically) the Ordinary General Meeting held physically at the company’s registered office.
All the resolutions have been approved, i.e.:
– The remuneration report, the discharge of the Directors and the Auditor;
– The 2024 annual accounts and the allocation of profits, including a total gross dividend of EUR 1.10 for fiscal year 2024 (such dividend is made up, on the one hand, of the interim dividend of EUR 0.50 gross per existing share, paid in November 2024 and, on the other hand, of a balance of EUR 0.60 gross per share payable upon detachment of the coupon 38);
- The renewal of the mandate of 7 Capital SRL, represented by Mrs. Chantal De Vrieze, as Director;
- The appointment of PricewaterhouseCoopers SRL as statutory auditor for the coming three years.
Due to the lack of attendance quorum, the Extraordinary General Meeting convened on the same day has been postponed to June 10, 2025, at 12:00 pm.
All documents relating to the Ordinary General Meeting of May 20, 2025, including a summary of the votes, can be found on our company website www.evs.com.
About EVS
We create return on emotion
EVS is globally recognized as a leading provider in live video technology for broadcast and new media productions. Spanning the entire production process, EVS solutions are trusted by production teams worldwide to deliver the most gripping live sports images, buzzing entertainment shows and breaking news to billions of viewers every day – and in real time. As we continue to expand our footprint, our dedication to sustainable growth for both our business and the industry is clearly demonstrated through our ESG strategy. This commitment is not only reflected in our results, but also in our high ratings from different agencies.
Headquartered in Liège, Belgium, the company has a global presence with offices in Australia, Asia, the Middle East, Europe, North and Latin America, employing over 700 team members and ensuring sales, training, and technical support to more than 100 countries.
EVS is a public company traded on Euronext Brussels: EVS, ISIN: BE0003820371. EVS is, amongst others, part of the Euronext Tech Leaders and Euronext BEL Mid indices.
Media Contacts
For more info about this press release, or to set up an interview with EVS, please contact:
Veerle De Wit – Chief Financial Officer
Tel: +32 4 361 7004 – Email: v.dewit@evs.com
Sébastien Verlaine – Senior Brand & Corporate Communications Manager
Tel: +32 4 361 5809 – Email: s.verlaine@evs.com
Forward Looking Statements
This press release contains forward-looking statements with respect to the business, financial condition, and results of operations of EVS and its affiliates. These statements are based on the current expectations or beliefs of EVS’s management and are subject to a number of risks and uncertainties that could cause actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements. These risks and uncertainties relate to changes in technology and market requirements, the company’s concentration on one industry, decline in demand for the company’s products and those of its affiliates, inability to timely develop and introduce new technologies, products and applications, and loss of market share and pressure on pricing resulting from competition which could cause the actual results or performance of the company to differ materially from those contemplated in such forward-looking statements. EVS undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Attachment
- Press release in PDF format
- Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma - June 12, 2025
- Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network - June 12, 2025
- CREDIT AGRICOLE SA: Crédit Agricole Santé & Territoires announces the signing of an agreement to acquire Petits-fils, the leading provider of at-home services for seniors in France, from Clariane - June 12, 2025
